Literature DB >> 18824845

Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.

S Yi1, G Contreras, E R Miller, L J Appel, B C Astor.   

Abstract

BACKGROUND/AIMS: The N-amino-terminal fragment of the prohormone B-type natriuretic peptide (NT-proBNP) is a marker of cardiac stress and elevated levels are indicative of heart failure. Few correlates of NT-proBNP levels have been identified in persons with moderate chronic kidney disease (CKD), and data from those without heart failure and from African Americans are especially limited.
METHODS: The African American Study of Kidney Disease and Hypertension (AASK) enrolled nondiabetic African Americans with hypertensive kidney disease (glomerular filtration rate [GFR] = 20-65 ml/min/1.73 m(2)) and no evidence of clinical heart failure. NT-proBNP was measured in 982 AASK participants.
RESULTS: In unadjusted analyses, GFR (r = -0.39; p < 0.001), hematocrit (r = -0.21; p < 0.001) and body mass index (BMI; r = -0.07; p = 0.04) were inversely correlated, and systolic blood pressure (r = 0.30; p < 0.001) and log UPCR (r = 0.32; p < 0.001) were positively correlated with log NT-proBNP levels. After adjustment for potential confounders, lower GFR and hematocrit and higher systolic blood pressure and protein:creatinine ratio remained significantly associated with higher NT-proBNP.
CONCLUSION: Lower GFR and hematocrit, and higher urinary protein excretion may be associated with volume expansion in CKD. These results suggest that these processes are associated with increased NT-proBNP in CKD and may play a role in the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824845      PMCID: PMC2786020          DOI: 10.1159/000159276

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  27 in total

Review 1.  The clinical epidemiology of cardiovascular disease in chronic kidney disease.

Authors:  John Shik; Patrick S Parfrey
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-11       Impact factor: 2.894

2.  Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Authors:  J T Wright; J W Kusek; R D Toto; J Y Lee; L Y Agodoa; K A Kirk; O S Randall; R Glassock
Journal:  Control Clin Trials       Date:  1996-08

3.  Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.

Authors:  T Omland; A Aakvaag; H Vik-Mo
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

4.  Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.

Authors:  S Wiese; T Breyer; A Dragu; R Wakili; T Burkard; S Schmidt-Schweda; E M Füchtbauer; U Dohrmann; F Beyersdorf; D Radicke; C J Holubarsch
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

5.  Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Brad C Astor; Donna K Arnett; Andrew Brown; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

Review 6.  Cardiovascular complications in chronic kidney disease.

Authors:  Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

7.  Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.

Authors:  Raquel Cortés; Miguel R Otero; Pedro Morillas; Esther Roselló-Lletí; Lilian Grigorian; Luís Martínez-Dolz; Fernando G de Burgos; Jose R Calabuig; Federico Soria; Teresa Lozano; Manuel Portolés; Vicente Bertomeu
Journal:  Am J Hypertens       Date:  2008-04-24       Impact factor: 2.689

8.  Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

Authors:  Jennifer J Gassman; Tom Greene; Jackson T Wright; Lawrence Agodoa; George Bakris; Gerald J Beck; Janice Douglas; Ken Jamerson; Julia Lewis; Michael Kutner; Otelio S Randall; Shin-Ru Wang
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

10.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

View more
  5 in total

Review 1.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

2.  A multi-marker approach to predict incident CKD and microalbuminuria.

Authors:  Caroline S Fox; Philimon Gona; Martin G Larson; Jacob Selhub; Geoffrey Tofler; Shih-Jen Hwang; James B Meigs; Daniel Levy; Thomas J Wang; Paul F Jacques; Emelia J Benjamin; Ramachandran S Vasan
Journal:  J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 10.121

3.  High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Nisha Bansal; Amanda Hyre Anderson; Wei Yang; Robert H Christenson; Christopher R deFilippi; Rajat Deo; Daniel L Dries; Alan S Go; Jiang He; John W Kusek; James P Lash; Dominic Raj; Sylvia Rosas; Myles Wolf; Xiaoming Zhang; Michael G Shlipak; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 10.121

4.  Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis.

Authors:  Shihui Fu; Yi Guo; Zhao Zhang; Leiming Luo; Ping Ye
Journal:  BMC Nephrol       Date:  2018-04-23       Impact factor: 2.388

5.  Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Nisha Bansal; Leila Zelnick; Alan Go; Amanda Anderson; Robert Christenson; Rajat Deo; Christopher Defilippi; James Lash; Jiang He; Bonnie Ky; Stephen Seliger; Elsayed Soliman; Michael Shlipak
Journal:  J Am Heart Assoc       Date:  2019-10-24       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.